- Home
- KMDA vs TKNO Comparison
KMDA vs TKNO Comparison
Compare KMDA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- TKNO
- Stock Information
- Founded
- KMDA 1990
- TKNO 1996
- Country
- KMDA Israel
- TKNO United States
- Employees
- KMDA N/A
- TKNO N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- KMDA Health Care
- TKNO Health Care
- Exchange
- KMDA Nasdaq
- TKNO Nasdaq
- Market Cap
- KMDA 398.5M
- TKNO 340.9M
- IPO Year
- KMDA N/A
- TKNO 2021
- Fundamental
- Price
- KMDA $6.95
- TKNO $5.38
- Analyst Decision
- KMDA Strong Buy
- TKNO
- Analyst Count
- KMDA 2
- TKNO 0
- Target Price
- KMDA $13.00
- TKNO N/A
- AVG Volume (30 Days)
- KMDA 77.7K
- TKNO 261.4K
- Earning Date
- KMDA 11-12-2025
- TKNO 11-06-2025
- Dividend Yield
- KMDA 2.88%
- TKNO N/A
- EPS Growth
- KMDA 27.97
- TKNO N/A
- EPS
- KMDA 0.32
- TKNO N/A
- Revenue
- KMDA $169,517,000.00
- TKNO $38,923,000.00
- Revenue This Year
- KMDA $14.49
- TKNO $9.52
- Revenue Next Year
- KMDA $10.12
- TKNO $15.20
- P/E Ratio
- KMDA $21.01
- TKNO N/A
- Revenue Growth
- KMDA 9.67
- TKNO 11.40
- 52 Week Low
- KMDA $5.43
- TKNO $3.94
- 52 Week High
- KMDA $9.16
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- KMDA 52.44
- TKNO 50.42
- Support Level
- KMDA $6.72
- TKNO $5.41
- Resistance Level
- KMDA $7.11
- TKNO $5.89
- Average True Range (ATR)
- KMDA 0.19
- TKNO 0.35
- MACD
- KMDA 0.03
- TKNO -0.02
- Stochastic Oscillator
- KMDA 60.68
- TKNO 53.85
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.